Nifty
:
25875.80
Sensex
:
84466.51
180.85 (0.70%)
595.19 (0.71%)
Nifty
Sensex
:
:
25875.80
84466.51
180.85 (0.70%)
595.19 (0.71%)

Cipla Ltd.

Pharmaceuticals & Drugs - Global

Rating :
65/99

BSE: 500087 | NSE: CIPLA

NSE BSE
1519.30
12-Nov-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1514.9
  •  1528.1
  •  1514.1
  •  1514.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1179131
  •  1792378997.4
  •  1673
  •  1335

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,22,773.15
  • 22.49
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,22,071.56
  • 1.05%
  • 3.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.21%
  • 0.53%
  • 13.83%
  • FII
  • DII
  • Others
  • 24.54%
  • 28.69%
  • 3.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.32
  • 7.53
  • 6.58

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.14
  • 10.90
  • 7.39

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.46
  • 16.97
  • 23.59

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.17
  • 29.65
  • 28.73

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.65
  • 3.99
  • 4.04

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.58
  • 16.21
  • 16.03

Earnings Forecasts:

(Updated: 08-11-2025)
Description
2024
2025
2026
2027
Adj EPS
65.29
60.92
65.2
72.4
P/E Ratio
23.27
24.94
23.30
20.98
Revenue
27145.4
29209.9
31606.6
34327
EBITDA
7127.9
7038.11
7455.84
8211.47
Net Income
5272.52
4987.43
5264.59
5805.36
ROA
15.04
12.49
11.83
11.91
P/B Ratio
3.93
3.49
3.12
2.81
ROE
18.21
14.74
14.04
14
FCFF
4081.18
4034.83
4071.51
4098.62
FCFF Yield
3.4
3.36
3.39
3.41
Net Debt
-7654.88
-10535
-12244.6
-14241.4
BVPS
386.24
435.02
486.56
540.8

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Net Sales
7,589.44
7,051.02
7.64%
6,957.47
6,693.94
3.94%
6,729.69
6,163.24
9.19%
7,072.97
6,603.81
7.10%
Expenses
5,694.69
5,165.43
10.25%
5,179.33
4,978.14
4.04%
5,192.10
4,847.38
7.11%
5,084.05
4,856.28
4.69%
EBITDA
1,894.75
1,885.59
0.49%
1,778.14
1,715.80
3.63%
1,537.59
1,315.86
16.85%
1,988.92
1,747.53
13.81%
EBIDTM
24.97%
26.74%
25.56%
25.63%
22.85%
21.35%
28.12%
26.46%
Other Income
268.95
190.61
41.10%
258.56
160.19
61.41%
289.46
249.33
16.10%
221.61
184.63
20.03%
Interest
13.18
15.40
-14.42%
14.05
17.95
-21.73%
14.02
17.59
-20.30%
14.64
30.10
-51.36%
Depreciation
296.99
271.74
9.29%
252.72
246.68
2.45%
308.73
288.34
7.07%
279.80
233.43
19.86%
PBT
1,853.53
1,789.06
3.60%
1,769.93
1,611.36
9.84%
1,504.30
1,259.26
19.46%
1,916.09
1,473.81
30.01%
Tax
500.46
483.04
3.61%
477.88
435.07
9.84%
279.28
324.86
-14.03%
332.37
405.30
-17.99%
PAT
1,353.07
1,306.02
3.60%
1,292.05
1,176.29
9.84%
1,225.02
934.40
31.10%
1,583.72
1,068.51
48.22%
PATM
17.83%
18.52%
18.57%
17.57%
18.20%
15.16%
22.39%
16.18%
EPS
16.73
16.13
3.72%
16.06
14.58
10.15%
15.13
11.63
30.09%
19.45
13.08
48.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
28,349.57
27,547.62
25,774.09
22,753.12
21,763.34
19,159.59
17,131.99
16,362.41
15,155.71
14,394.29
13,594.89
Net Sales Growth
6.93%
6.88%
13.28%
4.55%
13.59%
11.84%
4.70%
7.96%
5.29%
5.88%
 
Cost Of Goods Sold
9,121.45
8,928.99
8,819.57
8,252.28
8,495.60
7,351.89
5,991.42
5,784.49
5,438.42
5,317.12
5,089.86
Gross Profit
19,228.12
18,618.63
16,954.52
14,500.84
13,267.74
11,807.70
11,140.57
10,577.92
9,717.29
9,077.17
8,505.03
GP Margin
67.83%
67.59%
65.78%
63.73%
60.96%
61.63%
65.03%
64.65%
64.12%
63.06%
62.56%
Total Expenditure
21,150.17
20,419.72
19,483.04
17,762.83
17,251.38
14,910.94
13,951.18
13,494.26
12,702.32
11,918.50
11,115.22
Power & Fuel Cost
-
397.18
364.84
353.61
331.03
308.26
327.43
335.11
298.82
251.73
245.92
% Of Sales
-
1.44%
1.42%
1.55%
1.52%
1.61%
1.91%
2.05%
1.97%
1.75%
1.81%
Employee Cost
-
4,832.83
4,310.04
3,830.08
3,529.91
3,251.83
3,027.01
2,856.53
2,690.10
2,633.82
2,434.01
% Of Sales
-
17.54%
16.72%
16.83%
16.22%
16.97%
17.67%
17.46%
17.75%
18.30%
17.90%
Manufacturing Exp.
-
1,894.12
1,779.35
1,589.90
1,453.22
1,206.33
1,372.03
1,284.94
1,220.67
1,192.77
1,023.49
% Of Sales
-
6.88%
6.90%
6.99%
6.68%
6.30%
8.01%
7.85%
8.05%
8.29%
7.53%
General & Admin Exp.
-
1,791.63
1,673.94
1,423.23
1,206.07
986.01
1,289.13
1,096.50
1,002.43
868.31
845.89
% Of Sales
-
6.50%
6.49%
6.26%
5.54%
5.15%
7.52%
6.70%
6.61%
6.03%
6.22%
Selling & Distn. Exp.
-
1,834.86
1,724.97
1,694.30
1,670.00
1,298.62
1,252.04
1,281.29
1,082.90
1,009.21
818.76
% Of Sales
-
6.66%
6.69%
7.45%
7.67%
6.78%
7.31%
7.83%
7.15%
7.01%
6.02%
Miscellaneous Exp.
-
740.11
810.33
619.43
565.55
508.00
692.12
855.40
968.98
645.54
818.76
% Of Sales
-
2.69%
3.14%
2.72%
2.60%
2.65%
4.04%
5.23%
6.39%
4.48%
4.83%
EBITDA
7,199.40
7,127.90
6,291.05
4,990.29
4,511.96
4,248.65
3,180.81
2,868.15
2,453.39
2,475.79
2,479.67
EBITDA Margin
25.40%
25.87%
24.41%
21.93%
20.73%
22.18%
18.57%
17.53%
16.19%
17.20%
18.24%
Other Income
1,038.58
861.87
746.57
512.13
321.73
269.77
369.38
476.57
357.65
228.69
208.21
Interest
55.89
62.01
89.88
109.54
106.35
160.70
197.36
168.43
114.23
159.38
206.63
Depreciation
1,138.24
1,106.95
1,051.02
1,172.11
1,051.95
1,067.66
1,174.65
1,097.15
949.83
1,322.93
754.22
PBT
7,043.85
6,820.81
5,896.72
4,220.77
3,675.39
3,290.06
2,178.18
2,079.14
1,746.98
1,222.17
1,727.03
Tax
1,589.99
1,529.76
1,546.59
1,202.86
933.80
888.76
631.20
569.53
250.11
179.76
331.59
Tax Rate
22.57%
22.43%
27.12%
29.79%
26.73%
27.01%
28.98%
27.39%
14.98%
14.71%
19.20%
PAT
5,453.86
5,294.37
4,123.14
2,804.51
2,529.57
2,417.66
1,593.98
1,544.87
1,413.31
1,013.38
1,372.01
PAT before Minority Interest
5,461.29
5,291.05
4,155.31
2,835.49
2,559.47
2,401.30
1,546.98
1,509.61
1,419.35
1,042.41
1,395.44
Minority Interest
7.43
3.32
-32.17
-30.98
-29.90
16.36
47.00
35.26
-6.04
-29.03
-23.43
PAT Margin
19.24%
19.22%
16.00%
12.33%
11.62%
12.62%
9.30%
9.44%
9.33%
7.04%
10.09%
PAT Growth
21.60%
28.41%
47.02%
10.87%
4.63%
51.67%
3.18%
9.31%
39.46%
-26.14%
 
EPS
67.72
65.74
51.19
34.82
31.41
30.02
19.79
19.18
17.55
12.58
17.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
31,193.45
26,706.43
23,407.78
20,841.69
18,326.53
15,763.00
15,012.28
14,229.19
12,543.66
11,516.22
Share Capital
161.52
161.47
161.43
161.36
161.29
161.25
161.14
161.02
160.90
160.68
Total Reserves
30,917.81
26,458.42
23,184.53
20,636.35
18,123.15
15,548.70
14,794.10
14,001.91
12,320.74
11,266.12
Non-Current Liabilities
-31.04
81.92
183.53
621.70
1,660.47
2,972.37
4,646.15
4,259.05
4,514.99
1,407.13
Secured Loans
11.98
0.00
332.46
376.20
355.32
304.74
47.70
0.00
0.00
207.00
Unsecured Loans
0.00
0.00
-332.46
40.04
847.43
2,064.54
3,782.37
3,662.11
3,645.36
14.88
Long Term Provisions
148.69
129.26
102.16
100.22
116.17
133.27
121.41
137.92
140.52
144.68
Current Liabilities
5,483.96
5,245.77
5,033.27
4,912.87
4,591.14
4,393.14
3,771.51
3,832.22
3,388.91
7,776.05
Trade Payables
2,837.49
2,473.98
2,534.52
2,508.10
2,066.82
2,281.81
1,947.99
2,119.12
1,586.30
1,475.82
Other Current Liabilities
772.99
890.98
1,007.60
769.81
1,093.21
706.65
541.86
647.04
908.95
1,006.14
Short Term Borrowings
80.12
247.02
187.90
393.34
334.73
447.15
486.16
435.87
467.23
4,969.67
Short Term Provisions
1,793.36
1,633.79
1,303.25
1,241.62
1,096.38
957.53
795.50
630.19
426.43
324.42
Total Liabilities
36,742.17
32,130.02
28,930.34
26,651.95
24,837.20
23,422.79
23,761.91
22,672.90
20,885.79
21,049.49
Net Block
9,895.14
9,493.61
9,100.65
9,621.91
9,393.77
9,558.59
9,546.51
9,949.14
9,508.16
9,368.32
Gross Block
19,655.92
18,160.54
17,204.76
16,968.35
15,647.05
14,913.62
13,790.31
12,960.01
11,370.70
10,167.62
Accumulated Depreciation
9,707.76
8,573.36
7,994.72
7,310.84
6,216.82
5,309.30
4,233.78
3,010.87
1,609.71
799.30
Non Current Assets
13,453.65
12,688.61
11,731.79
11,924.75
11,656.17
11,716.61
11,335.28
11,858.80
12,082.23
12,208.26
Capital Work in Progress
1,566.27
1,152.72
1,093.30
766.18
968.89
824.53
676.18
981.33
1,682.98
2,060.87
Non Current Investment
639.54
642.21
572.52
355.63
545.43
578.80
490.20
157.66
137.36
176.35
Long Term Loans & Adv.
1,038.36
844.39
845.11
736.39
645.57
677.08
455.57
514.96
543.67
426.18
Other Non Current Assets
203.09
442.07
60.38
383.22
102.51
77.61
166.82
255.71
210.06
176.54
Current Assets
23,248.97
19,392.45
16,805.06
14,710.83
13,181.03
11,706.18
12,426.63
10,814.10
8,803.56
8,841.23
Current Investments
7,293.23
4,807.01
3,089.86
2,194.97
2,286.37
1,016.52
2,125.79
1,102.21
837.39
582.34
Inventories
5,642.11
5,237.95
5,156.43
5,350.24
4,669.18
4,377.60
3,964.83
4,044.70
3,519.72
3,808.05
Sundry Debtors
5,506.37
4,770.66
4,057.00
3,424.44
3,445.68
3,891.31
4,150.72
3,102.45
2,582.17
2,356.27
Cash & Bank
799.84
874.97
1,564.62
1,928.48
1,401.23
1,003.91
618.81
965.61
638.27
871.40
Other Current Assets
4,007.42
567.64
373.99
305.56
1,378.57
1,416.84
1,566.48
1,599.13
1,226.01
1,223.17
Short Term Loans & Adv.
3,481.42
3,134.22
2,563.16
1,507.14
1,031.03
974.82
1,150.95
1,118.93
807.84
780.03
Net Current Assets
17,765.01
14,146.68
11,771.79
9,797.96
8,589.89
7,313.04
8,655.12
6,981.88
5,414.65
1,065.18
Total Assets
36,702.62
32,081.06
28,536.85
26,635.58
24,837.20
23,422.79
23,761.91
22,672.90
20,885.79
21,049.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
5,004.98
4,133.91
3,237.65
3,325.90
3,755.20
3,068.45
1,691.14
1,462.76
2,381.76
1,740.81
PBT
6,820.81
5,896.72
4,220.77
3,675.39
3,290.06
2,178.18
2,079.14
1,669.46
1,222.17
1,727.03
Adjustment
517.74
640.77
878.19
967.47
1,130.91
1,365.53
1,268.77
1,293.82
1,374.42
950.85
Changes in Working Capital
-665.47
-806.10
-559.42
-177.46
371.66
372.99
-1,063.54
-778.48
235.44
-429.38
Cash after chg. in Working capital
6,673.08
5,731.39
4,539.54
4,465.40
4,792.63
3,916.70
2,284.37
2,184.80
2,832.03
2,248.50
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1,668.10
-1,597.48
-1,301.89
-1,139.50
-1,037.43
-848.25
-593.23
-722.04
-450.27
-507.69
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3,691.14
-2,988.03
-2,388.51
-1,871.88
-2,387.18
104.04
-1,668.68
-854.01
-1,310.21
-4,522.63
Net Fixed Assets
-626.50
-373.49
-600.42
-321.93
-437.48
-450.41
-173.16
-509.84
-889.04
1,487.25
Net Investments
-3,557.23
-1,884.41
-935.67
-1,124.06
-2,533.43
-1,439.15
-1,239.74
-351.09
-30.10
164.99
Others
492.59
-730.13
-852.42
-425.89
583.73
1,993.60
-255.78
6.92
-391.07
-6,174.87
Cash from Financing Activity
-1,292.79
-1,200.43
-958.29
-1,599.79
-1,239.51
-2,948.82
-348.72
-385.48
-1,325.68
3,104.06
Net Cash Inflow / Outflow
21.05
-54.55
-109.15
-145.77
128.51
223.67
-326.26
223.27
-254.13
322.24
Opening Cash & Equivalents
512.34
561.33
658.11
790.43
649.13
508.36
853.47
610.35
858.15
545.84
Closing Cash & Equivalent
542.65
512.34
561.33
658.11
790.43
742.38
508.36
853.46
610.35
858.15

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
384.84
329.72
289.24
257.78
226.73
194.85
185.62
175.92
155.15
142.23
ROA
15.36%
13.59%
10.19%
9.94%
9.95%
6.56%
6.50%
6.52%
4.97%
7.28%
ROE
18.34%
16.63%
12.85%
13.10%
14.13%
10.09%
10.37%
10.65%
8.72%
12.61%
ROCE
23.64%
22.77%
18.19%
17.24%
17.85%
12.53%
11.94%
10.20%
8.28%
13.24%
Fixed Asset Turnover
1.96
2.00
1.81
1.82
1.85
1.89
1.79
1.25
1.36
1.40
Receivable days
50.64
45.49
44.13
42.19
47.44
54.10
55.36
68.17
61.60
57.62
Inventory Days
53.61
53.56
61.98
61.53
58.49
56.12
61.13
90.71
91.41
100.43
Payable days
108.56
103.64
111.52
98.28
107.95
128.84
59.02
57.37
46.96
51.51
Cash Conversion Cycle
-4.31
-4.58
-5.41
5.44
-2.02
-18.63
57.47
101.50
106.05
106.55
Total Debt/Equity
0.00
0.01
0.02
0.04
0.10
0.18
0.29
0.29
0.33
0.46
Interest Cover
111.00
64.44
37.87
33.85
21.47
12.04
13.34
15.61
8.67
9.36

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Cipla to acquire Inzpera Healthsciences
    4th Nov 2025, 15:41 PM

    Upon acquisition, Inzpera will become wholly owned subsidiary of the company

    Read More
  • Cipla - Quarterly Results
    31st Oct 2025, 00:00 AM

    Read More
  • Cipla reports 4% rise in Q2 consolidated net profit
    30th Oct 2025, 15:51 PM

    The consolidated total income of the company increased by 8.52% at Rs 7,858.39 crore for Q2FY26

    Read More
  • Cipla enters into agreement with Eli Lilly and Company
    23rd Oct 2025, 17:18 PM

    Cipla has the rights to distribute and promote Yurpeak--the second brand of tirzepatide in India

    Read More
  • Cipla’s arm recalling over 20,000 packs of Ibuterol Sulfate Inhalation Aerosol
    28th Aug 2025, 14:18 PM

    The company is recalling 20,352 packs of the inhalation drug due to Failed Stability Specifications

    Read More
  • Cipla’s Bengaluru manufacturing facility classified as VAI by USFDA
    5th Aug 2025, 10:30 AM

    USFDA had conducted the inspection at said facility from May 26 to May 30, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.